ICON and Proteome Sciences partner on biomarkers
ICON and Proteome Sciences have formed a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

The Dublin-based ICON said it is including an integrated suite of labeling, separation and mass spectrometry technologies for protein and peptide profiling in complex biological materials through its alliance with Proteome's PS Biomarker Services.

ICON and Proteome Sciences are already engaged in their first joint project which is the development of a mass spectrometry assay for a key biomarker for an international pharmaceutical development company.